Stockscreener 앱 받기
8.08
7.16%
0.54
시간 외 거래:
8.00
-0.08
-0.99%
Arvinas Inc 주식(ARVN)의 최신 뉴스
Statistical indicators supporting Arvinas Inc.’s strengthEarnings Recap Report & AI Forecast Swing Trade Picks - Newser
Published on: 2025-08-27 13:32:23 - Newser
What institutional flow reveals about Arvinas Inc.July 2025 Snapshot & Fast Moving Market Watchlists - Newser
What MACD and RSI say about Arvinas Inc.Earnings Overview Summary & Weekly Top Gainers Trade List - Newser
What moving averages say about Arvinas Inc.July 2025 Pullbacks & High Accuracy Investment Signals - Newser
Will Arvinas Inc. stock go up soonQuarterly Trade Review & AI Driven Stock Movement Reports - Newser
How high can Arvinas Inc. stock goMarket Rally & Entry Point Confirmation Alerts - Newser
San Francisco investor pressures Arvinas after boosting stake; seeks cost cuts, drug pipeline shift - Hartford Business Journal
T. Rowe Price Investment Management Inc. Has $3.85 Million Stock Holdings in Arvinas, Inc. $ARVN - MarketBeat
Ranking Arvinas Inc. among high performing stocks via toolsMarket Risk Report & Reliable Intraday Trade Alerts - Newser
Arvinas Inc. stock daily chart insightsTrade Signal Summary & Safe Capital Allocation Plans - Newser
Published on: 2025-08-26 17:25:03 - Newser
Technical analysis overview for Arvinas Inc. stockJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
What Fibonacci levels say about Arvinas Inc. reboundRate Cut & Safe Capital Growth Stock Tips - Newser
Trend analysis for Arvinas Inc. this weekJuly 2025 Sector Moves & Growth Focused Stock Reports - Newser
Applying big data sentiment scoring on Arvinas Inc.Portfolio Gains Summary & Low Risk High Win Rate Picks - Newser
Trendlines Suggest Arvinas Inc. May Bottom Out SoonJuly 2025 PreEarnings & Consistent Growth Equity Picks - beatles.ru
Vanguard Group Inc. Acquires 1,299,639 Shares of Arvinas, Inc. $ARVN - MarketBeat
Using data filters to optimize entry into Arvinas Inc.2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Arvinas Inc. Recovers — But Is It SustainableJuly 2025 Analyst Calls & Reliable Price Breakout Signals - beatles.ru
Using economic indicators to assess Arvinas Inc. potentialJuly 2025 Catalysts & Smart Investment Allocation Insights - Newser
Using R and stats models for Arvinas Inc. forecastingShare Buyback & Daily Oversold Bounce Ideas - Newser
What indicators show strength in Arvinas Inc.Bond Market & Weekly High Potential Stock Alerts - Newser
Is Arvinas Inc. Stock a Good Fit for Conservative InvestorsTrade Volume Summary & AI Powered Buy and Sell Recommendations - Newser
Algert Global LLC Buys 257,879 Shares of Arvinas, Inc. $ARVN - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco - MSN
Live Scanner Shows Breakout on Arvinas Inc.July 2025 Reactions & Real-Time Volume Trigger Notifications - 더경남뉴스
Is Arvinas Inc. stock a good dividend stockPortfolio Return Report & Verified Entry Point Detection - theviewers.co.kr
Is Arvinas Inc. building a consolidation baseEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Arvinas' Surging Institutional Stake and Therapeutic Pipeline Momentum: A High-Conviction Biotech Play - AInvest
Can Arvinas Inc. Rally Enough to Break EvenBond Market & Technical Pattern Based Signals - beatles.ru
Does Arvinas Inc. meet Warren Buffett’s criteriaQuarterly Portfolio Report & Weekly Return Optimization Alerts - theviewers.co.kr
Arvinas' Strategic Crossroads: Logos Global's Aggressive Capital Return Proposal and the Path to Value Realization - AInvest
Logos Global Management Acquires 8.6% Stake in Arvinas, Inc. - AInvest
Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment - MSN
Published on: 2025-08-20 04:59:17 - Newser
Multi asset correlation models including Arvinas Inc.2025 Analyst Calls & Verified Entry Point Detection - Newser
Is Arvinas Inc. forming a reversal patternTrade Risk Summary & Long-Term Safe Investment Plans - Newser
0.98%
8.06%
자본화:
|
볼륨(24시간):